News

Female Viagra May Be Coming To A Chemist Near You Soon!

   

pill

Spout Pharmaceutical, a company hoping to develop a female version of Viagra called flibanserin, aka “female Viagra”, has again submitted the drug for the Food and Drug Administration’s review on Tuesday. This will make it the third time that the company has submitted it for FDA approval, they have been denied twice.

The FDA has explained that they declined to approve flibanserin because it does not work well enough to justify the side effects like drowsiness, diarrhoea, headaches, indigestion and some other long term effects.

As the Associated Press reports,

For decades, drugmakers have tried unsuccessfully to develop a female equivalent to Viagra, the blockbuster drug that treats men’s erectile dysfunction drug by increasing blood flow. But disorders of women’s sexual desire have proven resistant to drugs that act on blood flow, hormones and other simple biological functions.

Supporters of Sprout’s drug say women’s sexual disorders have been overlooked for too long by regulators at the Food and Drug Administration. But critics argue that women’s sexuality is too complex to be addressed by a single pill.

Sprout’s drug flibanserin is the first attempt to increase libido by acting on brain chemicals linked to appetite and mood. But the Food and Drug Administration has already twice rejected the drug because of lackluster effectiveness and side effects including fatigue, dizziness and nausea.

In an effort to break the regulatory logjam, groups sponsored by Sprout and other drugmakers have begun publicizing the lack of a “female Viagra” as a women’s rights issue.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

For Adverts & Enquiries:

Email: info@woman.ng

Copyright © 2015 Woman.NG. Designed by Soft Runner

To Top